Haematology Pathways
19 pathways
Work through 19 interactive haematology decision pathways — branching, guideline-grounded workflows that take you from presentation to assessment, risk stratification and management. Each pathway cites its source (NICE, ESC, AHA and specialty guidance), embeds the relevant calculators, and makes escalation and safety-netting explicit. For decision support only — apply clinical judgement and local protocols.
- Deep Vein Thrombosis Diagnosis and TreatmentWells score, D-dimer, USS, and anticoagulation for DVTNICE CG144 / NICE NG158
- Sickle Cell CrisisVaso-occlusive crisis and acute chest syndrome management in sickle cell diseaseBSH 2021 / BCSH
- Neutropenic SepsisEmergency management of febrile neutropaenia — MASCC score and antibiotic escalationNICE CG151 2012 / ESMO
- Anticoagulation ReversalReversal of warfarin, DOACs, and heparins for major bleeding or emergency surgeryBSH 2016 / ESC
- Blood Transfusion — Indications and SafetyRestrictive transfusion thresholds, consent, and transfusion reactionsBSH 2012 / NICE
- Acute Myeloid Leukaemia PresentationAcute Myeloid Leukaemia Presentation clinical pathway.BSH; NICE — NG146
- Tumour Lysis SyndromeTumour Lysis Syndrome clinical pathway.Cairo-Bishop; BSH; NICE — Best Practice
- Iron Deficiency AnaemiaBSG 2021 — diagnosis (ferritin, transferrin saturation), GI investigation in adults, iron replacement (oral vs IV), recurrence assessment.BSG 2021; BSH
- B12 / Folate DeficiencyBSH 2014 — diagnosis, distinguish pernicious anaemia, urgent treatment if neuro features, B12 replacement schedule, dietary advice.BSH 2014; NICE CKS
- Immune Thrombocytopenia (ITP)Diagnosis of exclusion, treatment by platelet count + bleeding, steroid + IVIG first-line, second-line TPO-RA / rituximab.ASH 2019; BSH 2018
- Disseminated Intravascular Coagulation (DIC)Diagnose with ISTH criteria, treat underlying cause, blood product replacement, anticoagulation in selected.BSH 2009; ISTH
- Thrombotic Microangiopathy (TTP / HUS / aHUS)MAHA + thrombocytopenia — TTP (ADAMTS13), HUS (Shiga toxin / atypical), drug-induced — urgent plasma exchange for TTP.BSH 2023; KDIGO
- Acute Transfusion ReactionsRecognise + classify transfusion reactions, immediate management, SHOT reporting, prevention.BSH 2018; SHOT
- Multiple Myeloma — Diagnostic WorkupCRAB criteria, immunoglobulin / free light chains, bone marrow, imaging, induction therapy.BSH 2021; IMWG
- Heparin-Induced Thrombocytopenia (HIT)4Ts pre-test probability, ELISA + functional assay, immediate non-heparin anticoagulant (argatroban / fondaparinux), avoid platelet transfusion.BSH 2012; ASH 2018
- Acute Lymphoblastic Leukaemia — PresentationRecognise pancytopenia + blasts + lymphadenopathy / mediastinal mass, urgent referral, induction chemotherapy.BSH 2021; NCCN
- Polycythaemia / Myeloproliferative Neoplasm WorkupDistinguish PV / ET / MF — JAK2 mutation, secondary causes, symptom-directed therapy, thrombosis risk reduction.BSH 2018; WHO 2022
- Inherited Thrombophilia WorkupIndications for testing, panel composition, when NOT to test, anticoagulation duration based on results.BSH 2010; ISTH
- Lymphoma Diagnostic PathwayB-symptoms, staging (Ann Arbor / Lugano), excisional biopsy, staging investigations, MDT, treatment by type/stage.BSH 2024; NICE NG52